Status:
RECRUITING
Physical Activity and Fibrosing Interstitial Lung Disease
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Fibrotic Interstitial Lungs Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Fibrotic interstitial lungs diseases (ILD) are a group of chronic and rare diseases characterized by an altered blood oxygenation in the lung, leading to dyspnea and physical limitation. Physical trai...
Detailed Description
60 patients with fibrosing interstitial lung disease will be included in this study. Initial assessments at the beginning will be conducted for an overview of initials abilities and divided in 3 sessi...
Eligibility Criteria
Inclusion
- Patient aged ≥ 18 years
- Fibrosing PID with fibrosis score \> 10% of lung volume on chest CT scan
- Be able to attend physical reconditioning 3 times a week
- Be affiliated to a health insurance scheme
- Sign informed consent form
Exclusion
- Any contraindication to physical activity (hereafter, after Dany-Michel Marcadeta, Bruno Pavy et al. Recommendations of the French Society of Cardiology for stress tests 2018)
- Be unable to perform exercise on an ergocycle or treadmill
- Be unable to perform a stress test, particularly for people on long-term oxygen therapy rest oxygen therapy at home
- IRS during an exacerbation
- Change in treatment \< 3 months
- Sarcoidosis
- Connectivitis
- Pregnancy in progress
- Participation in a therapeutic intervention study
- Patient under guardianship
- Person subject to a legal protection measure
- Patient on state medical aid
Key Trial Info
Start Date :
November 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06182748
Start Date
November 30 2023
End Date
January 30 2026
Last Update
October 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Exercise and Sports Medicine Department
Bobigny, Seine Saint Denis, France, 93009